This prospective study evaluated the plasma and intrapulmonary pharmacokinetics and pharmacodynamics (PKPD) of posaconazole (POS) in lung transplant recipients. and 1 60 We concluded that a dosage of 400 mg Bet resulted in suffered plasma NVP-BHG712 ELF and AC concentrations above the MIC90 for spp. through the dosing period. Confirmation from the healing value of… Continue reading This prospective study evaluated the plasma and intrapulmonary pharmacokinetics and pharmacodynamics